Azithromycin-13C-d3

Azithromycin-13C-d3 Suppliers list
Company Name: Artis Biotech Co. Ltd.  
Tel: 18108108965 18108108965
Email: sales@artisbio.com
Company Name: Guangzhou Younan Technology Co., Ltd  
Tel: 020-82000279 18988941452
Email: YN_research@163.com
Company Name: CHINA ISOTOPE CO., LIMITED  
Tel: 02151600108 13062666369
Email: info@isotopechem.com
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Company Name: TLC Pharmaceutical Standards Ltd.  
Tel: 18012923235
Email: chinasales04@tlcstandards.com.cn
Azithromycin-13C-d3 Basic information
Product Name:Azithromycin-13C-d3
Synonyms:13C,D3-Azithromycin;Azithromycin-13C-D3;Azithromycin-[13C.D3] (Standard)
CAS:2750534-82-6
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Azithromycin-13C-d3 Structure
Azithromycin-13C-d3 Chemical Properties
solubility Chloroform: soluble
Safety Information
MSDS Information
Azithromycin-13C-d3 Usage And Synthesis
DescriptionAzithromycin-13C-d3 is intended for use as an internal standard for the quantification of azithromycin (Item No. 15004) by GC- or LC-MS. Azithromycin is a macrolide antibiotic.1 It is active against S. pneumoniae, S. aureus, N. gonorrhoeae, M. pneumoniae, H. pylori, C. trachomatis, and H. influenzae in vitro (MIC90s = <0.01-2 mg/L). Azithromycin increases survival in mouse models of intraperitoneal S. pyogenes, S. pneumoniae, E. faecalis, or H. influenzae infection (ED50s = 0.78, 8.7, 12.7, and 30.3 mg/kg, respectively).2 It inhibits replication of severe acute respiratory coronavirus 2 (SARS-CoV-2), but not Middle East respiratory syndrome CoV (MERS-CoV), when used at concentrations of 5 and 10 µM.3 Azithromycin also decreases plasma levels of IL-6, TNF-α, and IL-1β and increases survival in a mouse model of LPS-induced sepsis when administered at a dose of 100 mg/kg.4 Formulations containing azithromycin have been used in the treatment of a variety of bacterial infections.WARNING This product is not for human or veterinary use.
References[1] M S KANATANI  B J G. The new macrolides. Azithromycin and clarithromycin.[J]. The Western journal of medicine, 1994, 160 1: 31-37.
[2] D GIRARD. Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.[J]. Journal of Antimicrobial Chemotherapy, 2005, 56 2: 365-371. DOI: 10.1093/jac/dki241
[3] AHMED MOSTAFA. FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2.[J]. ACS Applied Energy Materials, 2020. DOI: 10.3390/ph13120443
[4] ANASUYA PATEL. Azithromycin in Combination with Ceftriaxone Reduces Systemic Inflammation and Provides Survival Benefit in a Murine Model of Polymicrobial Sepsis.[J]. ACS Applied Energy Materials, 2018. DOI: 10.1128/aac.00752-18
Azithromycin-13C-d3 Preparation Products And Raw materials
Tag:Azithromycin-13C-d3(2750534-82-6) Related Product Information
Azithromycin Erythromycin-13C,d3 AZITHROMYCIN-D3 Azelastine-13C-d3 (hydrochloride) Clarithromycin-13C-d3 Rapamycin